Asia's 2nd-largest manufacturer of synthetic food, drug & cosmetic colours, exporting to 80+ countries.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 124 | 157 | 212 | 246 | 276 | 297 | 306 | 324 |
| Borrowings | 34 | 31 | 90 | 52 | 20 | 66 | 60 | 58 |
| Other Liabilities | 23 | 33 | 44 | 29 | 24 | 29 | 43 | 33 |
| Total Liabilities | 186 | 226 | 352 | 332 | 325 | 397 | 414 | 420 |
| AssetsFixed Assets | 31 | 29 | 38 | 47 | 125 | 126 | 135 | 133 |
| CWIP | 2 | 5 | 33 | 65 | 0 | 0 | 0 | 0 |
| Investments | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Other Assets | 140 | 179 | 268 | 207 | 187 | 258 | 266 | 274 |
| Total Assets | 186 | 226 | 352 | 332 | 325 | 397 | 414 | 420 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 22 | 28 | 11 | -22 | 96 | 63 | -5 | 42 |
| Cash from Investing | -4 | -17 | -3 | -40 | -42 | -19 | -7 | -16 |
| Cash from Financing | -8 | -19 | -8 | 53 | -47 | -40 | 19 | -35 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 18 | 23 | 8 | -62 | 53 | 44 | -12 | 26 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (56.8×) and current (28.9×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 8.8% growth and a 29× exit, ₹284 only delivers your return if you pay ₹186. The price is currently baking in 17% growth.
EPS grows 8.8%/yr for 5 years, then fades to 6% over 2, exits at 29×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 8.8% | 10.71 |
| FY28 | 8.8% | 11.65 |
| FY29 | 8.8% | 12.67 |
| FY30 | 8.8% | 13.79 |
| FY31 | 8.8% | 15.00 |
| FY32 | 7.4% ·fade | 16.11 |
| FY33 | 6.0% ·fade | 17.08 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.